Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPAGLIFLOZIN Cause Transient ischaemic attack? 391 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 391 reports of Transient ischaemic attack have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 1.8% of all adverse event reports for DAPAGLIFLOZIN.

391
Reports of Transient ischaemic attack with DAPAGLIFLOZIN
1.8%
of all DAPAGLIFLOZIN reports
2
Deaths
118
Hospitalizations

How Dangerous Is Transient ischaemic attack From DAPAGLIFLOZIN?

Of the 391 reports, 2 (0.5%) resulted in death, 118 (30.2%) required hospitalization, and 100 (25.6%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 391 reports have been filed with the FAERS database.

What Other Side Effects Does DAPAGLIFLOZIN Cause?

Death (2,775) Diabetic ketoacidosis (1,773) Acute kidney injury (982) Off label use (891) Nausea (884) Dehydration (860) Vomiting (838) Dizziness (817) Ketoacidosis (803) Fatigue (785)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which DAPAGLIFLOZIN Alternatives Have Lower Transient ischaemic attack Risk?

DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN DAPAGLIFLOZIN vs DAPRODUSTAT DAPAGLIFLOZIN vs DAPSONE DAPAGLIFLOZIN vs DAPTOMYCIN

Related Pages

DAPAGLIFLOZIN Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack DAPAGLIFLOZIN Demographics